Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
Hartwell D, Jones J, Baxter L, Shepherd J
Record ID 32010000269
English
Authors' recommendations:
Study found that patients may be successfully treated with a shorter course of peginterferon and ribavirin combination therapy without compromising the likelihood of achieving a sustained virological response. Economic evaluation showed that treatment with peginterferon alfa in specified subgroups of patients yielded quality-of-life gains without excessive increases in costs.
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/2043
Year Published:
2011
URL for published report:
https://www.ncbi.nlm.nih.gov/books/NBK99718/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Adult
- Ribavirin
- Hepatitis C, Chronic
- Interferon-alpha
- HIV Infections
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.